Association between Streptococcus pneumoniae And COVID-19 Co-infection in Patients with Severe Respiratory Diseases
DOI:
https://doi.org/10.24126/jobrc.2025.19.2.826Keywords:
Streptococcus pneumoniae, Coronavirus -19, multiple drug resistance, severe respiratory distress syndromeAbstract
Background: Streptococcus pneumoniae bacteria are Gram-positive, round to lancelet in morphology. Arranged in pairs (diplococci), they cause opportunistic infections when spread from the nasopharynx to other body locations, like typical pneumonia, septicemia, meningitis, and otitis media.Methodology: In this cross-sectional study, A hundred samples of sputum were taken at Baghdad teaching hospitals and other hospitals of the medical city from individuals suffering from respiratory tract infections. 50% of patients were diagnosed with pneumonia had COVID-19 positive. These samples were analyzed by several techniques (Gram stain, optochin sensitivity, and catalase, biofilm, and HiCrome agar as selective media), then cultured on Mueller-Hinton agar (M.H.) for antibiotic sensitivity. Conclusion: This study indicates the presence of highly resistant pneumococcus with multiple drug resistance (MDR) ability; the most effective antibiotic in this study was meropenem, which inhibits these bacterial pathogens.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Suhaib K. Ibrahim

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the creative commons Attribution (CC BY) 4.0 license which permits unrestricted use, distribution, and reproduction in any medium or format, and to alter, transform, or build upon the material, including for commercial use, providing the original author is credited.